
|Articles|October 1, 2003
Supplements and Featured Publications
- Biopharmaceutical Agents for Treating Rheumatoid Arthritis: Impact on Patients and Managed Care Heal
- Volume 9
- Issue 6 Suppl
Treatment Compliance and Dosage Administration Among Rheumatoid Arthritis Patients Receiving Infliximab, Etanercept, or Methotrexate
Advertisement
Articles in this issue
over 22 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
2
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
3
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
4
β-Blockers Show No Added Benefit After MI With Preserved LVEF
5



























































